S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Urgent Warning (Ad)
Factory or farm? Oregon may alter land use for chipmakers
Travel disruption hits Germany on eve of transport strike
Urgent Warning (Ad)
Adele extends Las Vegas residency, plans concert film
Berlin climate proposal fails to get enough yes votes to win
Urgent Warning (Ad)
Turkmenistan votes for new, opposition-free parliament
Technical issues at Lufthansa cause delays in Frankfurt
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Urgent Warning (Ad)
Factory or farm? Oregon may alter land use for chipmakers
Travel disruption hits Germany on eve of transport strike
Urgent Warning (Ad)
Adele extends Las Vegas residency, plans concert film
Berlin climate proposal fails to get enough yes votes to win
Urgent Warning (Ad)
Turkmenistan votes for new, opposition-free parliament
Technical issues at Lufthansa cause delays in Frankfurt
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Urgent Warning (Ad)
Factory or farm? Oregon may alter land use for chipmakers
Travel disruption hits Germany on eve of transport strike
Urgent Warning (Ad)
Adele extends Las Vegas residency, plans concert film
Berlin climate proposal fails to get enough yes votes to win
Urgent Warning (Ad)
Turkmenistan votes for new, opposition-free parliament
Technical issues at Lufthansa cause delays in Frankfurt
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Urgent Warning (Ad)
Factory or farm? Oregon may alter land use for chipmakers
Travel disruption hits Germany on eve of transport strike
Urgent Warning (Ad)
Adele extends Las Vegas residency, plans concert film
Berlin climate proposal fails to get enough yes votes to win
Urgent Warning (Ad)
Turkmenistan votes for new, opposition-free parliament
Technical issues at Lufthansa cause delays in Frankfurt
NASDAQ:AEMD

Aethlon Medical - AEMD Stock Forecast, Price & News

$0.38
+0.01 (+2.40%)
(As of 03/24/2023 08:50 PM ET)
Add
Compare
Today's Range
$0.37
▼
$0.40
50-Day Range
$0.37
▼
$0.70
52-Week Range
$0.23
▼
$2.46
Volume
29,100 shs
Average Volume
1.09 million shs
Market Capitalization
$8.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Aethlon Medical MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.81% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.93mentions of Aethlon Medical in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From $0.69 to ($0.55) Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.50 out of 5 stars

See Top Rated MarketRank™ Stocks Here

AEMD stock logo

About Aethlon Medical (NASDAQ:AEMD) Stock

Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment is involved in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in 1991 and is headquartered in San Diego, CA.

Receive AEMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aethlon Medical and its competitors with MarketBeat's FREE daily newsletter.

AEMD Stock News Headlines

March 26, 2023 | americanbankingnews.com
Aethlon Medical (NASDAQ:AEMD) Coverage Initiated by Analysts at StockNews.com
March 20, 2023 | americanbankingnews.com
Aethlon Medical (NASDAQ:AEMD) Now Covered by Analysts at StockNews.com
March 27, 2023 | Behind the Markets (Ad)
Buy THIS stock before Taiwan is attacked
... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.
February 17, 2023 | finance.yahoo.com
Aethlon Medical Third Quarter 2023 Earnings: US$0.12 loss per share (vs US$0.16 loss in 3Q 2022)
February 16, 2023 | finance.yahoo.com
Analysts Expect Aethlon Medical, Inc. (NASDAQ:AEMD) To Breakeven Soon
February 15, 2023 | finance.yahoo.com
AEMD: New CRO to Help Advance Studies; Expanded Team to Facilitate Efforts
February 14, 2023 | finance.yahoo.com
Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2023 Earnings Call Transcript
February 14, 2023 | finanznachrichten.de
Aethlon Medical, Inc.: Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update
March 27, 2023 | Behind the Markets (Ad)
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
January 31, 2023 | finance.yahoo.com
Aethlon Medical to Present at Sequire Biotechnology Conference on February 2nd, 2023
January 30, 2023 | msn.com
Aethlon stock soars ~40% on pact for Hemopurifier clinical program in cancer
January 30, 2023 | marketwatch.com
Aethlon Medical Shares Soar 66% on NAMSA Clinical Trial Contract
January 30, 2023 | finance.yahoo.com
Aethlon Medical Announces Contract with NAMSA to Advance Hemopurifier Clinical Programs in Cancer
November 16, 2022 | finance.yahoo.com
AEMD: Hemopurifier Hemopurifier To Be Studied in a Variety of Solid Tumors
November 15, 2022 | seekingalpha.com
Aethlon Medical, Inc. (AEMD) Q2 2022 Earnings Call Transcript
November 12, 2022 | msn.com
Preview: Aethlon Medical's Earnings
November 2, 2022 | finance.yahoo.com
Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2022
October 18, 2022 | seekingalpha.com
AEMD Aethlon Medical, Inc.
September 17, 2022 | finance.yahoo.com
Aethlon Medical, Inc. (AEMD)
September 6, 2022 | finance.yahoo.com
Aethlon Medical to Present at Two Investor Conferences in September
August 17, 2022 | finance.yahoo.com
AEMD: Positive Results in a Range of Conditions, Including COVID-19 & Monkey Pox
August 15, 2022 | finance.yahoo.com
Aethlon Medical, Inc. (NASDAQ:AEMD) Is About To Turn The Corner
August 10, 2022 | seekingalpha.com
Aethlon Medical, Inc.'s (AEMD) CEO Chuck Fisher on Q1 2023 Results - Earnings Call Transcript
August 10, 2022 | finance.yahoo.com
Aethlon Medical To Start Lab Studies For Hemopurifier For Monkeypox
August 3, 2022 | finance.yahoo.com
Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 9, 2022
July 28, 2022 | finance.yahoo.com
Aethlon Medical Announces Publication of Peer-Reviewed Journal Article Describing Hemopurifier Resin Binding of Seven COVID-19 Variants
July 11, 2022 | nasdaq.com
FDA Approves Aethlon Medical's Protocol Amendment For COVID-19 Trial
See More Headlines
Receive AEMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aethlon Medical and its competitors with MarketBeat's FREE daily newsletter.

AEMD Company Calendar

Last Earnings
11/09/2021
Today
3/26/2023
Fiscal Year End
3/31/2023
Next Earnings (Estimated)
6/27/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AEMD
CUSIP
N/A
CIK
773910
Web
www.aethlonmedical.com
Phone
(858) 459-7800
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.74)
Trailing P/E Ratio
N/A
Forward P/E Ratio
0.55
P/E Growth
N/A
Net Income
$-10,420,000.00
Net Margins
N/A
Pretax Margin
-102,684.61%
Return on Equity
-77.32%
Return on Assets
-66.47%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
7.46
Quick Ratio
7.46

Sales & Book Value

Annual Sales
$290,000.00
Price / Sales
30.10
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.10 per share
Price / Book
0.35

Miscellaneous

Outstanding Shares
22,970,000
Free Float
22,234,000
Market Cap
$8.73 million
Optionable
Not Optionable
Beta
1.25

Key Executives

  • Charles J. Fisher
    Chief Executive Officer & Director
  • James B. Frakes
    Chief Financial Officer, Secretary & Senior VP
  • Annette Marleau
    Research Director
  • Steven P. LaRosa
    Chief Medical & Scientific Officer
  • Guy F. Cipriani
    Director, Chief Business Officer & Senior VP

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions













AEMD Stock - Frequently Asked Questions

Should I buy or sell Aethlon Medical stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Aethlon Medical in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" AEMD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AEMD, but not buy additional shares or sell existing shares.
View AEMD analyst ratings or view top-rated stocks.

How have AEMD shares performed in 2023?

Aethlon Medical's stock was trading at $0.2754 at the beginning of 2023. Since then, AEMD shares have increased by 38.0% and is now trading at $0.38.
View the best growth stocks for 2023 here.

When is Aethlon Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 27th 2023.
View our AEMD earnings forecast.

How were Aethlon Medical's earnings last quarter?

Aethlon Medical, Inc. (NASDAQ:AEMD) issued its quarterly earnings results on Tuesday, November, 9th. The medical equipment provider reported ($0.13) earnings per share for the quarter, beating analysts' consensus estimates of ($0.15) by $0.02. The medical equipment provider had revenue of $0.13 million for the quarter, compared to analysts' expectations of $0.21 million. During the same quarter in the previous year, the company earned ($0.15) EPS.

What other stocks do shareholders of Aethlon Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aethlon Medical investors own include Amarin (AMRN), Nokia Oyj (NOK), Vaxart (VXRT), VBI Vaccines (VBIV), Nabriva Therapeutics (NBRV), CRISPR Therapeutics (CRSP), Novavax (NVAX), Organigram (OGI), AT&T (T) and Aurora Cannabis (ACB).

What is Aethlon Medical's stock symbol?

Aethlon Medical trades on the NASDAQ under the ticker symbol "AEMD."

Who are Aethlon Medical's major shareholders?

Aethlon Medical's stock is owned by many different retail and institutional investors. Top institutional investors include Jane Street Group LLC (0.84%), HRT Financial LP (0.62%), Renaissance Technologies LLC (0.60%) and Concourse Financial Group Securities Inc. (0.00%).
View institutional ownership trends.

How do I buy shares of Aethlon Medical?

Shares of AEMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Aethlon Medical's stock price today?

One share of AEMD stock can currently be purchased for approximately $0.38.

How much money does Aethlon Medical make?

Aethlon Medical (NASDAQ:AEMD) has a market capitalization of $8.73 million and generates $290,000.00 in revenue each year. The medical equipment provider earns $-10,420,000.00 in net income (profit) each year or ($0.74) on an earnings per share basis.

How can I contact Aethlon Medical?

Aethlon Medical's mailing address is 9635 GRANITE RIDGE DRIVE SUITE 100, SAN DIEGO CA, 92123. The official website for the company is www.aethlonmedical.com. The medical equipment provider can be reached via phone at (858) 459-7800 or via email at susan@sanoonan.com.

This page (NASDAQ:AEMD) was last updated on 3/27/2023 by MarketBeat.com Staff